105 results about "Allergic purpura" patented technology

The invention relates to a medicament for treating allergic purpura, which is prepared from the following raw materials in portion by weight: 25-35 portions of astragalus root, 10-14 portions of radixscrophulariae, 18-22 portions of rehmanniae praeparatum, 18-22 portions of forsythia, 18-22 portions of rehmanniae vaporata, 9-11 portions of angelica, 18-22 portions of red paeonia, 7-9 portions ofcortex moutan, 18-22 portions of lithospermum, 14-16 portions of double blossom, 18-22 portions of agrimony, 5-7 portions of liquorice, 2-4 portions of safflower, 14-16 portions of salvia miltiorrhiza, 9-11 portions of sanguisorba, 9-11 portions of cattail pollen, 2-4 portions of rush, 9-11 portions of divaricate saposhnikovia root, 14-16 portions of rhizoma belamcandae, 14-16 portions of couchgrass root, 9-11 portions of medlar, 9-11 portions of indigowoad root and 9-11 portions of atractylodes macrocephala. The invention has the advantages of good curative effect, quick response, no toxic and side effects, low cost, convenient taking, treatment of both principal and secondary aspect of disease and no relapse, and can ensure that patients obtain good clinical effect after taking for 3-5 courses.

The invention relates to lithospermum oil and a preparation method thereof. The lithospermum oil is formed by lithospermum and sesame oil or rap oil according to the component ratio of 1 to 3, is prepared by the method of cleaning and chopping, mixing and soaking, waterproof cooking, aseptic filtration and storage for standby, solves the problem that no economic, applicable, convenient and effective Chinese medicine preparation is used for treating disposable diaper dermatitis of infants, does not need to be orally taken, is economic and convenient, has no adverse reaction and side effect, has ideal treatment effect, is currently the best Chinese medicine preparation for treating disposable diaper dermatitis of the infants, and is also suitable for treating diseases such as edema pain, pimple, tetter, dermatitis, exfoliative inflammation of lips, anaphylactoid purpura and so on.

The invention provides a medicament for treating allergic purpura, which is prepared from the following raw material medicaments in part by weight: 10 to 15 parts of Japanese thistle herb, 10 to 15 parts of common cephalanoplos herb, 5 to 10 parts of periostracum cicada, 10 to 15 parts of rehmannia root charcoal, 10 to 15 parts of baical skullcap root charcoal, 10 to 15 parts of garden burnet root charcoal,15 to 20 parts of lalang grass rhizome, 10 to 15 parts of the root bark of the peony tree, 10 to 15 parts of twotooth achyranthes root, 10 to 20 parts of poria, 15 to 20 parts of largehead atractylodes rhizome, 10 to 15 parts of red peony root, and 6 to 12 parts of raw liquorice. The raw material medicaments can be prepared into various conventional oral preparations by Chinese medicinal preparation conventional methods. The medicament has the functions of eliminating pathogenic heat from the blood, removing stasis to stop bleeding and resisting allergy, can treat both the symptoms and root causes of allergic purpura with perfect curative effect, and prevents relapse after healing. Clinical observation of 896 patients proves that the total effective rate of the medicament reaches 89.7 percent.

The invention relates to a glycyrrhizic acid derivative, preparation thereof and use thereof. The derivative has high water solubility and high storage stability and is suitable to be used in medicaments and health-care products for treating or preventing hepatitis, liver cirrhosis, hemorrhagic fever of liver damage and liver dysfunction syndrome, allergic purpura, psoriasis vulgaris, eczematousdermatitis and the like.

The invention discloses a Chinese medicinal composition for treating allergic purpura. The composition comprises the following components in percentage by mass: 5.1 to 7.1 percent of argy wormwood leaves, 5.1 to 7.1 percent of dark plum fruit, 5.1 to 7.1 percent of donkey-hide glue, 5.1 to 7.1 percent of Chinese angelica, 5.1 to 7.1 percent of honeysuckle flower, 5.1 to 7.1 percent of sophora flower, 5.1 to 7.1 percent of liquorice root, 2 to 4 percent of rhubarb, 7.4 to 9.4 percent of radix rehmanniae, 5.1 to 7.1 percent of redroot gromwell root, 5.1 to 7.1 percent of moutan bark of tree peony, and 33 to 35 percent of Chinese date, wherein the total content of the components is 100 percent; and the components are decocted with water. The Chinese medicinal composition has the characteristics of quick response, good curative effect, complete treatment and relapse prevention.

The invention relates to an extraction method of mouse platelet. Blood drawn from orbita vein of mouse is placed into an anticoagulation centrifugal tube, centrifugated at the speed of 800rmp for 10min after standing for 30min, and the extracted supernatant fluid is plasma rich in platelet. The supernatant fluid is placed in a clean test tube and centrifugated at the speed of 3500rpm for 10min. After filtering the supernatant fluid, the sediments at the bottom of the tube are the platelets. 50ul to 100ul of ammonium oxalate solution with a mass concentration of 1 percent is added into the test tube and slightly stirred with a glass rod, and then 2ml to 3ml of ammonium oxalate solution with a mass concentration of 1 percent is added, and stood for 5min, to make sure the hematid is dissolved; the hematid is centrifugated at the speed of 3500rpm for 10min, after the supernatant fluid is abandoned, the test tube is added with a few platelet scrub solution and blown and beaten to turn the platelet into a platelet suspension. The suspension is centrifugated at the speed of 3300rpm for 10min, removed the supernatant in the suspension, the test tube is added with a few platelet scrub solution and blown and beaten to turn the platelet into a platelet suspension. The platelet is used as an antigen to immunify guinea pigs, and the serum of such guines pigs is injected into the mouse to prepare allergic purpura. The preparation method has simple operation, can obtain high concentration platelet, and can comparatively better solve the problem of impure platelet.

The invention relates to a traditional Chinese medicine for treating allergic purpura, and the traditional Chinese medicine is composed of pharmaceutical raw materials with the following mixture ratio by weight: 0.5-0.8g of antelope horn powder, 20-25g of dried rehmannia root, 10-15g of sinkiang arnebia root, 10-15g of tree peony bark, 10-15g of red paeony root, 30-40g of lalang grass rhizome, 10-15g of India madder root, 30-40g of hairyvein agrimonia herb and bud, 10-15g of fineleaf schizonepeta herb, 10-15g of cicada slough, 30-40g of raw gypsum, 6-9g of stir-fried common anemarrhena rhizome, 6-9g of stir-fried cape jasmine fruit, 12-15g of gambir plant, 3-5g of stewed rhubarb and 6-9g of raw liquoric root. The traditional Chinese medicine has simple prepration, low cost, wide range of medicine sources, convenient use, rapid efficacy, high cure rate and no toxicity or side effects; the effective rate is 95 percent and the cure rate is 80 percent after the years of clinical applications.

The invention relates to a traditional Chinese medicine compound preparation for treating allergic purpura. The compound preparation is characterized by preparing from 100-370 g of lithospermum, 100-500 g of dandelions, 100-250 g of cortex moutan, 100-230 g of cortex dictamni, 100-300 g of radix paeoniae alba, 100-300 g of eclipta, 100-500 g of common cephalanoplos herbs, 75-300 g of achyranthes bidentata, 50-240 g of liquorice, 100-400 g of dried rehmannia roots and 100-400 g of poria cocos. The traditional Chinese medicine compound preparation provided by the invention has functions of detoxifying, cooling blood and removing stasis, and can relieve symptoms in short time, shorten course of treatment, reduce repetition of condition, reduce probability of occurrence of kidney damage, and has no hormones stage effect. The traditional Chinese medicine compound preparation has good application prospect and significant social benefits and economic benefits.

The invention discloses a food protein specific IgA antibody detection ELISA kit and an application thereof. The food protein specific IgA antibody detection ELISA kit comprises diluent, an antigen-coated ELISA plate, a plate washing solution, a standard product, negative control, a biotin secondary antibody, an avidin-HRP solution, a developing solution and stop buffer . The kit can be applied tothe detection of patients with IgA-related diseases such as allergic purpura (IgA vasculitis), IgA nephropathy, rheumatoid arthritis, juvenile idiopathic arthritis, systemic lupus erythematosus and the like so as to explore the correlation between the patients and food allergy proteins, which is conducive to the prevention and treatment of diseases. At the same time, the food protein specific IgAantibody detection ELISA kit satisfies the quality control standards of clinical food specific antibody detection kits (enzyme-linked immunosorbent assay) used in domestic hospitals, as well as the ELISA principle, characteristics and influence factors.

The invention aims to provide a date pancake with rich nutriment and good taste. The technical proposal adopted by the invention comprises that: date is washed, pitted, dried and milled for standby; soy bean, millet, sorghum and corn are used as main raw materials; walnut, sesame, date, and the like are used as auxiliary materials; the weight ratios comprise: 40 to 45 percent of the millet, 15 to 20 percent of the sorghum, 4 to 6 percent of the soy bean, 2 to 3 percent of the walnut, 1 to 2 percent of the sesame, 15 to 20 percent of the corn and 6 to 7 percent of the date; and the raw materials are milled into fine powder, spread on a griddle for frying and dried for eating. The pancake has date taste and is delicious, and has good auxiliary treatment effects on insomnia, allergic purpura, chronic nephritis and spontaneous sweating due to deficiency of vital energy.

The invention relates to application of oxymatrine (oxymatrine and matrine) and glycyrrhizic acid or pharmaceutically-acceptable forms of oxymatrine and glycyrrhizic acid or derivatives of oxymatrine and glycyrrhizic, a medicine containing the compositions, also comprises matrine glycyrrhizinate and oxymatrine glycyrrhizinate, and application of the compositions to prepare medicines treating cutaneous vasculitis (allergic cutaneous vasculitis, allergic purpura, erythema elevatum diutinum, acute febrile neutrophilic dermatosis, urticarial vasculitis, pustular vasculitis, polyarteritis nodosa, pyoderma gangrenosum, eosinophilic vasculitis, eosinophilic cellulitis, pigmented purpuric dermatoses, Wegener's granulomatosis, Behcet's disease, erythema nodosum, and erythema induratum).

The invention relates to a Chinese medicinal composition for treating dermatitis, allergic purpura, psoriasis and herpes zoster. The composition comprises 10 g of Herba Schizonepetae, 10 g of Radix Saposhnikoviae, 10 g of Radix Angelicae Sinensis, 10 g of Radix Gentianae Marcrophyllae, 10 g of Glycyrrhizae Radix, 10 g of Rhizoma Atractylodis, 6 g of Periostracum Cicadae, 30 g of Caulis Lonicerae, 10 g of Cortex Moutan, and10 g of Radix Paeoniae Rubra. In treatment, the above materials are added with water 1,500 mL, boiled with strong fire, decocted with slow fire for 40 min, and filtered to obtain decoction. One above dosage amount is administered every day, with seven days as a treatment course. The composition treats both manifestation and root cause of skin diseases, and has definite effects, and little toxic and side effects.

The invention discloses an oral administration pharmaceutical composition for treating allergic purpura, wherein the active constituents include the following raw material herbs (by weight portion): agkistrodon acutus 16g, rhizome of Sichuan lovage 12g, Chinese angelica root 12g, dried rehmannia root 16g, cicada shell 3g, root of red rooted saliva 16g, root bark of tree peony 12g, cogongrass rhizome 15g, alkanna tinctoria 10g, plaster stone 3g and licorice root 5g. The medicament should be decocted in water for the oral dose.

The invention provides application of a rhinoceros horn and rehmannia glutinosa composition in preparation of a medicine for preventing and treating related rash caused by an epidermal growth factor receptor inhibitor. The rhinoceros horn and rehmannia glutinosa composition includes rhinoceros horns, radix paeoniae rubra, radix rehmanniae and cortex moutan serving as effective ingredients. The medicine composition prepared by rhinoceros horn and rehmannia glutinosa decoction for treating severe hepatitis, hepatic coma, uremia, allergic purpura, acute leukemia, sepsis syndrome and other symptoms is creatively used for preventing and treating the rash caused by the epidermal growth factor receptor inhibitor, is better in clinical curative effect and low in toxicity and can be taken for a long time.

The present invention discloses a prescription, a preparing method, a usage, a main pharmacodynamics research result and the poisonous character research result for treating allergy purpuric by using a pure Chinese medicinal preparation. The prescription has characterizes of including raw materials by weight as follows: buffalo horn 6-150 parts, scutellaria 3-75 parts, groomwell root 3-75 parts, bark of peony root 3-75 parts, kitool (carbon) 4-100 parts, hairy vein agrimony 3-75 parts, radix scrophulariae 2-50 parts, flower of honeysuckle 4-100 parts, capsule of weeping forsythia 2-50 parts and sophora root 4-100 parts. The prescription originates from empirical prescription, adds, reduces and cut for forming according with traditional chinese medicine theory and many years clinical empirical. The prescription is reasonable and has functions of heat-clearing and antitoxic tablet, blood-cooling and hemostatic for treating allergy purpura. The prescription has favorable antianaphylaxis and hemostasia action, and can remove purpura in a short time. The prescription has rapid effect and reliable curative effect. The preparation has reasonable preparing technique and strong operability which is suitable for industrialization producing.

The invention relates to the field of medicament formulas, in particular to sinkiang arnebia root-honeysuckle flower-red paeony root-Chinese arborvitae twig soup for treating allergic purpura. The soup is characterized by consisting of the following bulk pharmaceuticals in percentage by weight: 5-8 percent of inkiang arnebia root, 8-11 percent of honeysuckle flower, 7-9 percent of red paeony root, 5-7 percent of Chinese arborvitae twig, 5-7 percent of tree peony bark, 4-6 percent of crude rehmannia, 4-6 percent of fineleaf schizonepeta herb, 3-6 percent of divaricate saposhnikovia root, 3-6 percent of figwort, 5-7 percent of dwarf lilyturf root, 3-5 percent of Chinese atractylodes, 8-11 percent of cogongrass rhizome, 4-7 percent of red-rooted salvia root, 2-4 percent of liquoric root, 2-4 percent of pseudo-ginseng root powder, 6-9 percent of paniculate swallowwort root and 4-7 percent of lightyellow sophora root. A preparation method of the soup comprises the following steps of: packaging pseudo-ginseng root powder separately; soaking the other 16 types of bulk pharmaceuticals into water and decocting; and removing residues to obtain a filtrate, and adding pseudo-ginseng root powder to obtain sinkiang arnebia root-honeysuckle flower-red paeony root-Chinese arborvitae twig soup. The soup is low in cost, has a good curative effect on allergic purpura, is free from toxic and side effects, has the effects of detoxifying, promoting eruption, clearing heat, removing ecchymoses, cooling wind-heat, cooling blood, arresting bleeding and the like, and is suitable for simple type, joint type, abdominal type, kidney type and mixed type allergic purpura.

The invention relates to a traditional Chinese medicinal preparation for treating allergic purpura, which is mainly used for solving the problems that the existing treatment mode for treating allergic purpura has high relapse rate, long curative period and high treatment cost. The traditional Chinese medicinal preparation is characterized by comprising the following ingredients in parts by weight: 10-30 parts of radix rehmanniae, 10-25 parts of cortex moutan, 10-30 parts of cornu bubali, 10-30 parts of honeysuckle, 10-30 parts of folium isatidis, 10-30 parts of rhizoma imperatae, 10-30 parts of herba cirsii, 10-30 parts of liquorice, 10-30 parts of figwort root, 10-30 parts of lithospermum, 10-25 parts of rubia cordifolia and 10-30 parts of plaster. The traditional Chinese medicinal preparation for treating allergic purpura is low in cost, good in curative effect, quick in effectiveness, and not easy to relapse.

The present invention discloses a Chinese medicine for curing allergic purpura. Said Chinese medicine has the functions of clearing away heat, removing toxic material, removing heat from the blood and removing ecchymoses, and can obtain obvious therapeutic effect. Said Chinese medicine is made up by using 8 Chinese medicinal materials of krait / agkistrodon, ligusticum root, Chinese angelica root, dried / fresh rehmannia root, cicada molting, salvia root, moutan root bark and imperata root.

Immunomodulatory pharmaceutical composition, each pharmaceutical dosage unit contains interleukin-25u~1500u, interferon 15u~1000u, thymosin 0.5ug~25ug, transfer factor 0.00002u~0.0015u, hydrocortisone 30ug~150ug, and is made of poultry eggs As an attachment agent, the above drug is added into poultry eggs, stirred evenly, dried and crushed into powder, and packed into capsules. The pharmaceutical composition can induce and stimulate the immune response to achieve the purposes of curing, preventing and maintaining health. Due to the small dose of active ingredients, there is no adverse toxic or side effect. After treating abdominal smooth muscle spasm, allergic purpura, diabetes, and vertigo, the curative effect is satisfactory.

The invention discloses an oral administration pharmaceutical composition for treating allergic purpura, wherein the active constituents include the following raw material herbs (by weight portion): honeysuckle flower 10g, capsule of weeping forsythia 10g, alkanna tinctoria 10g, root bark of tree peony 10g, root of red rooted saliva 6g, dried rehmannia root 8g, cogongrass rhizome 10g, dragon's blood resin 10g, red phaseolus bean 20g. The medicament should be decocted in water for the oral dose.

The present invention discloses a drug for treating allergic purpura, which is prepared from raw materials of lithospermum root, rubia cordifolia root, isatis root, scrophularia, cuscuta chinensis, angelica sinensis, and panax notoginseng powder. The present invention has good using effects, exact curative effects and a high effective rate of above 75%.

The invention discloses a medicament used for treating allergic purpura. The medicament is prepared from gen-seng, largehead atractylodes rhizome, radix astragali, fructus jujubae, Chinese angelica, radix glycyrrhizae and longan according to a certain weight ratio. The medicament can be made into any common oral administration preparation. The medicament has functions of tonifying qi and spleen, nourishing blood and promoting blood circulation, cooling blood and removing toxic and regulating immunity. The medicament can be used for treating the allergic purpura with advantages of rapid effect, high cure rate and no recurrence.

The invention relates to the field of medicine formulas, in particular to medicine for treating allergic purpura. The medicine is characterized by being composed of, by weight, 27-32 parts of honeysuckle, 8-10 parts of phillyrin, 8-12 parts of paeonia suffruticosa, 10-20 parts of dried rehmannia root, 14-19 parts of agrimonia pilosa ledeb, 10-20 parts of shikonin, 25-35 parts of salviae miltiorrhizae, 10-20 parts of cacumen biotae, 15-20 parts of common cephalanoplos herb, 14-16 parts of rubia cordifolia, 13-17 parts of sophora japonica, 10-20 parts of white peony root, 14-16 parts of fructus kochiae, 10-13 parts of radix isatidis, 14-19 parts of radix cynanchi panicullati and 5-7 parts of radix glycyrrhizae, the raw materials are soaked in water after being mixed, and filtrate is obtained by removing dregs after decocting.

The invention discloses traditional Chinese medicine for treating allergic purpura. The traditional Chinese medicine for treating allergic purpura is prepared from Chinese herbal medicine of Chinese ixora leaves, rosette thistle herb, sargentg loryvine, betelnut, sulphur, processed ulmus macrocarpa hance seeds, golden lycoris bulb, phoenix eye nuts, gamboge, hydnocarpus oil, orpiment, maritime dock herb, Chinese wingnut roots, walnut oil, aedes albopictus, Chinese fevervine fruit, david christmashush bark and leaves, goldenshower senna fruit, thickfruit millettia seed or fruit and Indian python gall. The traditional Chinese medicine for treating allergic purpura has the advantages that the pure natural Chinese herbal medicine is used as raw materials; both symptoms and root causes are treated; the curative effect is exact; no toxic and side effects exist; and the recurrence cannot easily occur.

The invention provides application of a buffalo horn rehmannia root medicinal composition in preparing a medicament for preventing and treating related rash caused by an epidermal growth factor receptor inhibitor. The buffalo horn rehmannia root medicinal composition comprises buffalo horn, peony roots, rehmannia roots and tree peony root bark as effective components. The invention creatively usesthe medicinal composition of the buffalo horn rehmannia root decoction used for severe hepatitis, hepatic coma, uremia, allergic purpura acute leukemia, septicemia and other diseases to prevent and treat the rash caused by the epidermal growth factor receptor inhibitor. The composition has good clinical curative effect and low toxicity, and can be taken for a long time.